Safety Study of a Recombinant Human Plasminogen Activator to Treat Acute Ischemic Stroke.
NCT00418275 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2007-01-04
Summary
To evaluate the safety profiles of HTU-PA in patients with acute ischemic stroke.
Conditions
- Cerebrovascular Accident
Interventions
- GENETIC
-
Recombinant Human Plasminogen Activator (HTUPA)
Sponsors & Collaborators
-
Global Biotech
lead INDUSTRY
Principal Investigators
-
Han-Hwa Hu, M.D. · Taipei Veterans General Hospita-lNeurological Institute
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2001-04-30
- Completion
- 2004-06-30
Countries
- Taiwan
More Related Trials
-
Efficacy and Safety of SP-8203 in Patients With Ischemic Stroke Requiring rtPA
NCT04479449 ·Status: COMPLETED ·Phase: PHASE2
-
Human Umbilical Cord Blood Infusion in Patients with Acute Ischemic Stroke (AIS)
NCT06040476 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Study to Assess the Safety and Efficacy of THR-18 When Administered to Patients Suffering Acute Ischemic Stroke and Treated With Tissue Plasminogen Activator (tPA)
NCT01253512 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Butyphthalide in Combination With Recombinant Tissue Plasminogen Activator for Acute Ischemic Stroke
NCT03394950 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Intravenous Tissue-type Plasminogen Activator on Acute Ischemic Stroke Patients With Large Vessel Occlusions
NCT04170647 ·Status: UNKNOWN
-
Thrombolysis Treated With TNK-tPA in Acute Ischemic Stroke Patients （3T Stroke-II）
NCT05281549 ·Status: UNKNOWN ·Phase: PHASE2
-
Tenecteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events(TRACE)
NCT04676659 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Safety, Imaging and Clinical Outcomes of THR-18 in Acute Stroke Subjects Treated With tPA
NCT02572336 ·Status: UNKNOWN ·Phase: PHASE2
-
Tenecteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-Ⅱ
NCT04797013 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of r-PA Treating Patients With Acute Ischemic Stroke（RAISE）
NCT05295173 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Tenecteplase Intravenous Thrombolysis in Acute Posterior Circulation Ischemic Stroke Within 4.5-24 Hours After Onset
NCT07094763 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion
NCT01222117 ·Status: COMPLETED ·Phase: PHASE2
-
An International Observational Study of the Safety and Efficacy of Thrombolysis in Stroke
NCT02229890 ·Status: COMPLETED
-
Phase I Clinical Safety Study About Human Umbilical Cord Blood Monocyte in the Acute Ischemic Stroke
NCT02433509 ·Status: COMPLETED ·Phase: PHASE1
-
Pre-stroke Cognitive Status and Thrombolytic Therapy
NCT01713491 ·Status: COMPLETED
-
Safety and Feasibility of Argatroban, Tissue Plasminogen Activator and Intra-arterial Therapy in Stroke
NCT02448069 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess the Efficacy, Safety, and Pharmacokinetics of TB006 in Participants With Acute Ischemic Stroke
NCT05156827 ·Status: WITHDRAWN ·Phase: PHASE2
-
Thrombolysis With rhPro-UK in 4.5-6 Hours After Acute Ischemic Stroke in a Double-blinded,Controlled Trial
NCT03578822 ·Status: COMPLETED ·Phase: PHASE3
-
Thrombolysis Treated With TNK-tPA in Acute Ischemic Stroke Patients （3T Stroke-Ⅲ）
NCT05745259 ·Status: UNKNOWN ·Phase: PHASE3
-
Argatroban Plus R-tPA for Acute Ischemic Stroke
NCT03740958 ·Status: COMPLETED ·Phase: PHASE4
-
Intra-Arterial Tenecteplase Following Endovascular Thrombectomy for Large Vessel Occlusion Stroke
NCT06781385 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2
-
TPA in Acute Stroke With COVID Verus Non-COVID-19 Patients
NCT05258565 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Human Urinary Kallidinogenase Combined With Endovascular Therapy in Acute Ischemic Stroke With Large Vessel Occlusion
NCT06211712 ·Status: RECRUITING ·Phase: NA
-
Intra-arterial Bone-marrow Mononuclear Cells Infusion for Acute Ischemic Stroke
NCT02178657 ·Status: COMPLETED ·Phase: PHASE2
-
Combined Treatment With Alteplase (Rt-PA) and Cerebrolysin® in Acute Ischemic Hemispheric Stroke
NCT00840671 ·Status: COMPLETED ·Phase: PHASE3